Effect of intraoperative high-dose remifentanil on postoperative pain: a prospective, double blind, randomized clinical trial.

Remifentanil, an ultra-short-acting opioid, is widely used for pain control during surgery. However, regular dose (RD) remifentanil exacerbates postoperative pain in a dose-dependent manner. Recent studies suggest that high-dose (HD) remifentanil offers sustained analgesia in experimental studies. W...

Full description

Bibliographic Details
Main Authors: Yan-Ling Zhang, Peng Ou, Xiang-Hang Lu, Yan-Ping Chen, Jun-Mei Xu, Ru-Ping Dai
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2014-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3965388?pdf=render
_version_ 1811276912466591744
author Yan-Ling Zhang
Peng Ou
Xiang-Hang Lu
Yan-Ping Chen
Jun-Mei Xu
Ru-Ping Dai
author_facet Yan-Ling Zhang
Peng Ou
Xiang-Hang Lu
Yan-Ping Chen
Jun-Mei Xu
Ru-Ping Dai
author_sort Yan-Ling Zhang
collection DOAJ
description Remifentanil, an ultra-short-acting opioid, is widely used for pain control during surgery. However, regular dose (RD) remifentanil exacerbates postoperative pain in a dose-dependent manner. Recent studies suggest that high-dose (HD) remifentanil offers sustained analgesia in experimental studies. We thus hypothesized that intraoperative administration of high-dose remifentanil may attenuate postoperative pain.In this prospective, randomized, double blind, controlled clinical study, sixty patients undergoing thyroidectomy (18-60 years-of-age) received an intraoperative infusion of 0.2 (RD group) or 1.2 μg kg(-1) min(-1) (HD group) remifentanil during thyroidectomy. A visual analogue scale (VAS) was used to measure pain intensity. Mechanical pain threshold on the forearm was assessed using von Frey filaments before surgery (baseline), 2 h postoperatively and 18-24 h postoperatively. The primary outcome was to compare the difference of VAS score at different time points after operation and morphine consumption 24 h postoperatively between RD and HD groups. The second outcome was to compare the difference of mechanical pain thresholds in the forearm postoperatively between RD and the HD groups.VAS scores were lower 30 min postoperatively in the HD group (1.29 ± 1.67, 95% CI 0.64-1.94) compared with the RD group (2.21 ± 1.67, 95% CI 1.57-2.84) (t = 3.427, p = 0.0043, RD group vs. HD group). Postoperative morphine consumption was much lower in the HD group compared with the RD group (1.27 ± 1.88 mg vs. 0.35 ± 1.25 mg, p = 0.033). In both groups, mechanical pain threshold was decreased 18-24 h postoperatively (2.93 ± 0.209 Ln(g) vs. 3.454 ± 2.072 Ln(g), p = 0.032 in RD group; 2.910 ± 0.196 Ln(g) vs. 3.621 ± 0.198 Ln(g), p = 0.006 in HD group, 18-24 h postoperatively vs baseline).Intraoperative administration of high-dose remifentanil decreased VAS scores and morphine consumption postoperatively. Thus, modulation of intraoperative opiates may be a simple and effective method of postoperative pain management.This trial is registered in ClinicalTrials.gov, with the Name: Effect of Higher Doses of Remifentanil on Postoperative Pain in Patients Undergoing Thyroidectomy, and ID number: NCT01761149.
first_indexed 2024-04-13T00:06:19Z
format Article
id doaj.art-e66d1a2aee2f43c7a3c08d6fbc80c5e3
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2024-04-13T00:06:19Z
publishDate 2014-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-e66d1a2aee2f43c7a3c08d6fbc80c5e32022-12-22T03:11:14ZengPublic Library of Science (PLoS)PLoS ONE1932-62032014-01-0193e9145410.1371/journal.pone.0091454Effect of intraoperative high-dose remifentanil on postoperative pain: a prospective, double blind, randomized clinical trial.Yan-Ling ZhangPeng OuXiang-Hang LuYan-Ping ChenJun-Mei XuRu-Ping DaiRemifentanil, an ultra-short-acting opioid, is widely used for pain control during surgery. However, regular dose (RD) remifentanil exacerbates postoperative pain in a dose-dependent manner. Recent studies suggest that high-dose (HD) remifentanil offers sustained analgesia in experimental studies. We thus hypothesized that intraoperative administration of high-dose remifentanil may attenuate postoperative pain.In this prospective, randomized, double blind, controlled clinical study, sixty patients undergoing thyroidectomy (18-60 years-of-age) received an intraoperative infusion of 0.2 (RD group) or 1.2 μg kg(-1) min(-1) (HD group) remifentanil during thyroidectomy. A visual analogue scale (VAS) was used to measure pain intensity. Mechanical pain threshold on the forearm was assessed using von Frey filaments before surgery (baseline), 2 h postoperatively and 18-24 h postoperatively. The primary outcome was to compare the difference of VAS score at different time points after operation and morphine consumption 24 h postoperatively between RD and HD groups. The second outcome was to compare the difference of mechanical pain thresholds in the forearm postoperatively between RD and the HD groups.VAS scores were lower 30 min postoperatively in the HD group (1.29 ± 1.67, 95% CI 0.64-1.94) compared with the RD group (2.21 ± 1.67, 95% CI 1.57-2.84) (t = 3.427, p = 0.0043, RD group vs. HD group). Postoperative morphine consumption was much lower in the HD group compared with the RD group (1.27 ± 1.88 mg vs. 0.35 ± 1.25 mg, p = 0.033). In both groups, mechanical pain threshold was decreased 18-24 h postoperatively (2.93 ± 0.209 Ln(g) vs. 3.454 ± 2.072 Ln(g), p = 0.032 in RD group; 2.910 ± 0.196 Ln(g) vs. 3.621 ± 0.198 Ln(g), p = 0.006 in HD group, 18-24 h postoperatively vs baseline).Intraoperative administration of high-dose remifentanil decreased VAS scores and morphine consumption postoperatively. Thus, modulation of intraoperative opiates may be a simple and effective method of postoperative pain management.This trial is registered in ClinicalTrials.gov, with the Name: Effect of Higher Doses of Remifentanil on Postoperative Pain in Patients Undergoing Thyroidectomy, and ID number: NCT01761149.http://europepmc.org/articles/PMC3965388?pdf=render
spellingShingle Yan-Ling Zhang
Peng Ou
Xiang-Hang Lu
Yan-Ping Chen
Jun-Mei Xu
Ru-Ping Dai
Effect of intraoperative high-dose remifentanil on postoperative pain: a prospective, double blind, randomized clinical trial.
PLoS ONE
title Effect of intraoperative high-dose remifentanil on postoperative pain: a prospective, double blind, randomized clinical trial.
title_full Effect of intraoperative high-dose remifentanil on postoperative pain: a prospective, double blind, randomized clinical trial.
title_fullStr Effect of intraoperative high-dose remifentanil on postoperative pain: a prospective, double blind, randomized clinical trial.
title_full_unstemmed Effect of intraoperative high-dose remifentanil on postoperative pain: a prospective, double blind, randomized clinical trial.
title_short Effect of intraoperative high-dose remifentanil on postoperative pain: a prospective, double blind, randomized clinical trial.
title_sort effect of intraoperative high dose remifentanil on postoperative pain a prospective double blind randomized clinical trial
url http://europepmc.org/articles/PMC3965388?pdf=render
work_keys_str_mv AT yanlingzhang effectofintraoperativehighdoseremifentanilonpostoperativepainaprospectivedoubleblindrandomizedclinicaltrial
AT pengou effectofintraoperativehighdoseremifentanilonpostoperativepainaprospectivedoubleblindrandomizedclinicaltrial
AT xianghanglu effectofintraoperativehighdoseremifentanilonpostoperativepainaprospectivedoubleblindrandomizedclinicaltrial
AT yanpingchen effectofintraoperativehighdoseremifentanilonpostoperativepainaprospectivedoubleblindrandomizedclinicaltrial
AT junmeixu effectofintraoperativehighdoseremifentanilonpostoperativepainaprospectivedoubleblindrandomizedclinicaltrial
AT rupingdai effectofintraoperativehighdoseremifentanilonpostoperativepainaprospectivedoubleblindrandomizedclinicaltrial